The linkage between xenobiotic exposures and autoimmune diseases remains to be clearly defined. However, recent studies have raised the possibility that both genetic and environmental factors act synergistically at several stages or checkpoints to influence disease pathogenesis in susceptible populations. These observations predict that individuals susceptible to spontaneous autoimmunity should be more susceptible following xenobiotic exposure by virtue of the presence of predisposing background genes. To test this possibility, mouse strains with differing genetic susceptibility to murine lupus were examined for acceleration of autoimmune features characteristic of spontaneous systemic autoimmune disease following exposure to the immunostimulatory metals nickel and mercury. Although NiCI2 exposure did not exacerbate autoimmunity, HgCI2 significantly accelerated systemic disease in a strain-dependent manner. Mercury-exposed (NZB x NZW)F1 mice had accelerated lymphoid hyperplasia, hypergammaglobulinemia, autoantibodies, and immune complex deposits. Mercury also exacerbated immunopathologic manifestations in MRL+/+ and MR -Ipr mice. However, there was less disease acceleration in lpr mice compared with MRL+/+ mice, likely due to the fact that environmental factors are less critical for disease induction when there is strong genetic susceptibility. Non-major histocompatability complex genes also contributed to mercuryexacerbated disease, as the nonautoimmune AKR mice, which are H-2 identical with the MRL, showed less immunopathology than either the MRL//pr or MRL+/+ strains. This study demonstrates that genetic susceptibility to spontaneous systemic autoimmunity can be a predisposing factor for HgCI2-induced exacerbation of autoimmunity. Such genetic predisposition may have to be considered when assessing the immunotoxicity of xenobiotics. Additional comparative studies using autoimmune-prone and nonautoimmune mice strains with different genetic backgrounds will help determine the contribution that xenobiotic exposure makes in rendering sensitive populations susceptible to autoimmune diseases.
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However, recent studies have raised the possibility that both genetic and environmental factors act synergistically at several stages or checkpoints of disease pathogenesis (3).
This exacerbating role for environmental agents has been suggested by a number of studies that have shown that exogenous agents can accelerate the onset of autoimmunity in animal models (4) (5) (6) (7) . These studies predict that individuals susceptible to spontaneous autoimmunity should be more susceptible following xenobiotic exposure by virtue of the presence of predisposing background genes. Such accelerated disease would be expected to more closely resemble the immunologic features of idiopathic autoimmunity rather than that induced by xenobiotic exposure in a nonautoimmune-prone host.
The availability of animal models of systemic autoimmune disease provides a valuable resource with which to study the responses of a population sensitive to xenobiotic-induced acceleration of autoimmunity. Among the best-known animal models of human systemic autoimmune disease are those mouse strains that spontaneously develop features of systemic lupus erythematosus (SLE) (3, 8, 9) . Each of the lupus-prone strains has been derived from different genetic backgrounds, which results in both quantitative and qualitative differences in disease expression. In some cases specific features of autoimmune disease have been ascribed to individual genetic defects in individual strains (9) . Lupus-prone strains thus provide unique genetic backgrounds for the study of xenobiotic influences on the constellation of immunologic features that comprise systemic autoimmunity. The strains used in this study include (NZB x NZW)F1 (NZBWF1) (H-2dIz) female mice, which due to the influence of sex hormones develop systemic autoimmunity earlier in life than their male counterparts (3, 8) . Also examined were MRL (H-2k) mice, which consist of two substrains, MRLIIpr and MRL+/+ (3, 8) . In the MRLlIpr, autoimmunity occurs very early in life and is associated with massive lymphoproliferation due to abnormal Fas (CD95) expression. In contrast, the MRL+/+ substrain, which has normal Fas expression, develops less severe systemic autoimmune disease, with onset considerably later in life than the MRL//pr.
In order to compare the influence of nonmajor hisocompatability complex (MHC) genes on xenobiotic acceleration of autoimmunity, the nonautoimmune strain AKR (H-2k) from which the MRL substrains derive their H-2 was also tested.
Xenobiotics selected for study were two metals, mercury and nickel, known to produce distinctly different immunologic responses. Mercury induces autoimmunity in mice (10) and rats (11) and an immunemediated kidney disease in humans (12) . Mercury-induced autoimmunity (HgIA) in rodents is associated with three major pathologic sequelae-lymphoproliferation, hypergammaglobulinemia, and the development of autoimmunity-manifested as autoantibody production and immune complex disease (10, 11) . Elicitation of these pathologic features is dependent on genetic background, with lymphadenopathy occurring in most strains; autoimmunity is more restricted, being controlled in large part by the MHC (10). HgIA was initially thought to be a CD4+ T-helper (Th)2 response because of increased levels of predominantly interleukin (IL)-4, and IgGI autoantibodies after HgCl2 exposure (13) . However all the features of systemic autoimmunity (hypergammaglobulinemia, autoantibodies, immune complex deposits) are now known to be dependent upon the Thl cytokine interferon (IFN)-y (14) .
In contrast, exposure to nickel is associated with allergic rather than autoimmune reactions. Nickel elicits increases in nitric oxide production (15) , activation of nuclear factor-KB (16) , and delayed-type hypersensitivity (DTH) reactions in humans (17) and rodents (18) . Nickel-induced DTH is characterized by the presence of IFN-y-producing Thl and ThO CD4+ T cells (19) .
In were bled before the first injection and sacrificed on day 30; serum was stored at -70°C until use. Autopsies were performed as previously described (21) . Samples of kidney and spleen were harvested for analysis of immune complex deposition and histology (see "Tissue Complex Deposits" and "Light Microscopy").
Detection ofSerum Antibody
Antibodies nuclear antigens (ANA) were detected using HEp-2 cell slides (Bion Enterprises, Park Ridge, IL) as previously described (22) . Prior to assay, sera were diluted 100-fold in PBS containing 0.1% bovine gamma globulin (BGG), 0 Antichromatin antibodies were detected by enzyme-linked immunosorbent assay (ELISA) as previously described (24) . Sera were diluted 100-fold prior to assay, and chromatin-bound antibodies detected with horseradish peroxidase (HRP)-conjugated goat antimouse IgG (Caltag Laboratories) diluted 2,000-fold. Antichromatin monoclonal antibody ID12 was used as positive control (25) .
Serum Immunoglobulin Quantitation
Serum IgG, IgG1, and IgG2a levels were quantified by ELISA, essentially as previously described (26) . ELISA plates were coated with 200 pL of 2 pg/mL goat antimouse kappa light chain antibody (Caltag Laboratories) in PBS, and incubated overnight at 4°C. Plates were postcoated for 1 hr with 0.1% gelatin in PBS, followed by three washes with PBS-0.05% Tween 20. Sera were diluted in serum diluent (26) , and incubated at room temperature while shaking for 2.5 hr, followed by three washes with PBS-0.05% Tween 20. HRP-conjugated goat antimouse IgG, IgG1, or IgG2a antibodies (Caltag Laboratories) diluted in antiimmunoglobulin diluent (26) were added before incubation with shaking for 90 min. After three washes with PBS-0.05% Tween 20 and four washes with PBS, 2,2'-azinobis(3-ethylbenzthiazolinesulfonic acid) (ABTS) substrate solution was added and optical density read at 405 nm (OD405). Standard curves were generated by serial dilutions of polyclonal mouse reference serum containing predetermined levels of immunoglobulin isotypes and subclasses (The Binding Site, Birmingham, UK). Serum IgG, IgGI, and IgG2a concentrations were quantified by converting the average OD405 of duplicate wells to immunoglobulin concentrations by use of standard curves. Only serum dilutions that gave OD405 values falling within the linear portion of the standard curve were used to calculate immunoglobulin levels.
Tissue Immune Complex Deposits
Sections 2-to 3-mm thick of the kidney and spleen were snap frozen in isopentane-C02 and prepared for direct immunofluorescence as previously described (27) . Cryostat sections 4-to 5-pm thick were fixed in ethanol and incubated with serial dilutions of FITC-conjugated goat antibodies to IgG (,y-chain specific) or C3 (Southern Biotechnology Associates, Birmingham, AL). The end-point titer of the immune complex deposits was defined as the highest dilution of antibody at which specific fluorescence could be detected and was expressed as the reciprocal titer. A score of 0 was recorded when no specific fluorescence was detected at a dilution of 1/40. The presence of granular deposits in small and medium-size arteries was also examined. All histology slides were examined without knowledge of treatment given or other results.
Light Micrspy
A 2-to 3-mm thick section of kidney was immersed in Histochoice fixative (Amresco, Solon, IL), embedded in paraplast, and cut into 1-to 2-pm sections that were stained with periodic acid Schiff's reagent and with periodic acid silver methenamine. Slides were then examined by light microscopy without knowledge of treatment given or other results. The types of glomerular alteration were determined and the degree of endocapillary cell hyperplasia was scored for each animal as follows: 0 = normal, 0. Figure 1 ) in HgCl2-exposed NZBWF1 mice were markedly elevated above those found in either NiCl2-or PBS-exposed animals.
Exposure of NZBWF1 mice to mercury increased organ wet weight of spleen and cervical lymph nodes but not mesenteric lymph nodes when compared to PBS-and NiCl2-treated animals ( Table 2 ). All HgC12-treated mice developed very high titers of IgG and C3 deposits in glomeruli (Table 2) . Granular IgG deposits in the glomeruli were localized to the capillary loops in 3/8 mice, restricted to the mesangium in one mouse, Figure 2 ). Metal-and saline-exposed MRL/Ipr mice showed no significant differences in ANA and antichromatin antibody at the end of the treatment period; each of the groups developed antichromatin antibodies during the exposure period (Table 3 , Figure 3 ). Figure 3 ). Mercury-exposed MRL+/+ mice had larger cervical nodes than their control counterparts, but spleen weights were not increased and mesenteric nodes were smaller (Table 4 ). All MRL+I+ mice treated with HgCl2 showed glomerular and mesangial IgG deposits, whereas only 5/8 NiGC2-treated mice and 3/8 PBS-treated mice showed such deposits ( The most pronounced response to mercury exposure was observed in female NZBWF1 mice, considered to be the prototypic murine model for human lupus (11) . This strain exhibited lymphadenopathy in the spleen and the cervical lymph nodes, which drain the mercury injection site. NZBWF1 mice also had pronounced hypergammaglobulinemia. Most striking was the marked elevation in antichromatin autoantibodiesan autoantibody response characteristic of murine lupus (28) and idiopathic (29) and drug-related human lupus (30) but found less frequently in murine HgIA (31) . Extensive tissue deposits of immunoglobulin and complement, particularly in the vessels of the kidney, are consistent with the progressive glomerulonephritis of idiopathic disease in NZWBF1 mice (32) . The higher titer of glomerular deposits in the NZBWF1 compared to the MRL substrains is also consistent with the idiopathic picture in these strains (32) . These studies with mercury, and those with other exogenous agents (4, 7) , suggest that the NZBWF1 strain may be particularly suited to studies on xenobiotic-induced exacerbation of systemic autoimmunity. (33, 34) or unaffected (33) The MHC is a major contributor to both idiopathic lupus (3) and HgIA (31, 36) . It could therefore be argued that exacerbation of autoimmunity in lupus-prone mice is primarily due to an effect on H-2 genes and not acceleration of idiopathic disease per se. To examine this possibility, AKR mice, from which the MRL derives its H-2 genes, were exposed to mercury. Although the AKR possesses the H-2k haploytpe, which confers susceptibility to HgIA (31), the degree of autoimmunity elicited differed from that of MRL mice. AKR mice had predominant elevations of IgG2a, whereas MRL+/+ mice showed increased IgGl. HgC12-exposed MRL+/+ mice had more severe disease, with higher titers of antichromatin antibodies, increased deposits of IgG and C3 in kidney vessels, and histologic glomerular changes. This comparison between autoimmune-prone strains and an H-2 identical nonautoimmune strain demonstrates the influences of both non-MHC and non-Ipr genes on mercuryaccelerated systemic autoimmunity in mice predisposed to spontaneous disease. Furthermore (27) . In idiopathic SLE, disease is progressive, often leading to death (8, 9) . At the height of disease HgIA is associated with increased IL-4 and IgG1 autoantibodies (13) . In contrast, murine models of idiopathic SLE have autoantibodies of IgG2a and IgG2b isotypes (28) and elevations in IL-1 and IFN-,y (9) .
Several mechanisms have been postulated to account for mercury's autoimmunepromoting effects, including generation of cryptic T-cell determinants (37) or production of T cells reacting against self-class II (38) . The finding that mercury did not accelerate humoral responses in the presence of the lpr gene raises the possibility that mercury, like the Ipr defect, may act through inhibition of apoptosis. This would be consistent with the polyclonal lymphoid hyperplasia and immunoglobulin increases found in the MRL+/+ after mercury treatment. Mercury could possibly prevent apoptosis by interacting with the sulfhydryl moiety of cysteine in the active site of one or more caspases (39) that are involved in the signaling and effector pathways responsible for induction of apoptotic cell death.
Comparison between the MRL and AKR strains revealed the importance of studies with genetically related nonautoimmune strains in dissecting the contribution ofxenobiotic exposure to acceleration of idiopathic disease. Additional studies contrasting the genetically related autoimmune-prone BXSB (H-2b) and nonautoimmune C57BL/6 (H-2b) have also shown that mercury exposure exacerbates idiopathic autoimmunity (40) . The significance of such studies cannot be overstated. Human studies have shown that xenobiotic-induced disease, although exhibiting features of the idiopathic syndrome, may lack key pathologic sequlea and have dinical features not associated with idiopathic disease (2, 41) . Studies that seek to link xenobiotics with autoimmunity must therefore attempt to discriminate between xenobiotic-induced autoimmunity and xenobiotic-accelerated idiopathic disease. Comparative studies using genetically related autoimmune-prone and nonautoimmune mice might help determine the contribution that xenobiotic exposure makes in rendering sensitive populations susceptible to autoimmunity.
